Wang, Z.; Chen, Y.; Li, X.; Zhang, Y.; Zhao, X.; Zhou, H.; Lu, X.; Zhao, L.; Yuan, Q.; Shi, Y.;
et al. Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2. Cancers 2022, 14, 3592.
https://doi.org/10.3390/cancers14153592
AMA Style
Wang Z, Chen Y, Li X, Zhang Y, Zhao X, Zhou H, Lu X, Zhao L, Yuan Q, Shi Y,
et al. Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2. Cancers. 2022; 14(15):3592.
https://doi.org/10.3390/cancers14153592
Chicago/Turabian Style
Wang, Zitong, Yingying Chen, Xiaoyu Li, Yuhan Zhang, Xiaokun Zhao, Hao Zhou, Xuebo Lu, Lili Zhao, Qiang Yuan, Yunshu Shi,
and et al. 2022. "Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2" Cancers 14, no. 15: 3592.
https://doi.org/10.3390/cancers14153592
APA Style
Wang, Z., Chen, Y., Li, X., Zhang, Y., Zhao, X., Zhou, H., Lu, X., Zhao, L., Yuan, Q., Shi, Y., Zhao, J., Dong, Z., Jiang, Y., & Liu, K.
(2022). Tegaserod Maleate Suppresses the Growth of Gastric Cancer In Vivo and In Vitro by Targeting MEK1/2. Cancers, 14(15), 3592.
https://doi.org/10.3390/cancers14153592